Famciclovir "Generics"

Primær information

  • Handelsnavn:
  • Famciclovir "Generics" 250 mg filmovertrukne tabletter
  • Dosering:
  • 250 mg
  • Lægemiddelform:
  • filmovertrukne tabletter
  • Brugt til:
  • Mennesker
  • Medicin typen:
  • Allopatiske stof

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Famciclovir "Generics" 250 mg filmovertrukne tabletter
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • Lægemiddelstyrelsen - Danish Medicines Agency
  • Autorisationsnummer:
  • 43397
  • Sidste ændring:
  • 22-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

14-12-2017

FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide)

FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide)

[8-24-2011] The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients that the antidepressant Celexa (citalopram hydrobromide; also marketed as generics) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart.

FDA - U.S. Food and Drug Administration

11-12-2017

FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)

FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)

The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that preliminary results from a recently completed clinical study suggest that a 32 mg single intravenous dose of ondansetron (Zofran, ondansetron hydrochloride, and generics) may affect the electrical activity of the heart (QT interval prolongation), which could pre-dispose patients to develop an abnormal and potentially fatal heart rhythm known as Torsades de Pointes.

FDA - U.S. Food and Drug Administration

1-8-2017

FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines

FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines

The U.S. Food and Drug Administration (FDA) has determined that recent data for rosiglitazone-containing drugs, such as Avandia, Avandamet, Avandaryl, and generics, do not show an increased risk of heart attack compared to the standard type 2 diabetes medicines metformin and sulfonylurea.

FDA - U.S. Food and Drug Administration

27-6-2017

FDA Tackles Drug Competition to Improve Patient Access

FDA Tackles Drug Competition to Improve Patient Access

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review of generic drug applications where competition is limited.

FDA - U.S. Food and Drug Administration

19-4-2018

NITROFURANTOIN MACROCRYSTALS Capsule [Impax Generics]

NITROFURANTOIN MACROCRYSTALS Capsule [Impax Generics]

Updated Date: Apr 19, 2018 EST

US - DailyMed

18-4-2018

URSODIOL Tablet, Film Coated [Impax Generics]

URSODIOL Tablet, Film Coated [Impax Generics]

Updated Date: Apr 18, 2018 EST

US - DailyMed

11-4-2018

FAMCICLOVIR Tablet, Film Coated [Proficient Rx LP]

FAMCICLOVIR Tablet, Film Coated [Proficient Rx LP]

Updated Date: Apr 11, 2018 EST

US - DailyMed

30-3-2018

METHYLPHENIDATE HYDROCHLORIDE Tablet, Extended Release [Impax Generics]

METHYLPHENIDATE HYDROCHLORIDE Tablet, Extended Release [Impax Generics]

Updated Date: Mar 30, 2018 EST

US - DailyMed

20-3-2018

ESTRADIOL VAGINAL (Estradiol) Cream [Impax Generics]

ESTRADIOL VAGINAL (Estradiol) Cream [Impax Generics]

Updated Date: Mar 20, 2018 EST

US - DailyMed

2-3-2018

DEXMETHYLPHENIDATE HYDROCHLORIDE Capsule, Extended Release [Impax Generics]

DEXMETHYLPHENIDATE HYDROCHLORIDE Capsule, Extended Release [Impax Generics]

Updated Date: Mar 2, 2018 EST

US - DailyMed

2-3-2018

METAXALONE Tablet [Impax Generics]

METAXALONE Tablet [Impax Generics]

Updated Date: Mar 2, 2018 EST

US - DailyMed

2-3-2018

LEVALBUTEROL (Levalbuterol Hydrochloride) Solution [Impax Generics]

LEVALBUTEROL (Levalbuterol Hydrochloride) Solution [Impax Generics]

Updated Date: Mar 2, 2018 EST

US - DailyMed

5-2-2018

METHYLPHENIDATE HYDROCHLORIDE Capsule, Extended Release [Impax Generics]

METHYLPHENIDATE HYDROCHLORIDE Capsule, Extended Release [Impax Generics]

Updated Date: Feb 5, 2018 EST

US - DailyMed

30-1-2018

AX PHARMACEUTICAL CORP (Famciclovir) Powder [AX Pharmaceutical Corp]

AX PHARMACEUTICAL CORP (Famciclovir) Powder [AX Pharmaceutical Corp]

Updated Date: Jan 30, 2018 EST

US - DailyMed

22-1-2018

FAMCICLOVIR Tablet, Film Coated [AvKARE, Inc.]

FAMCICLOVIR Tablet, Film Coated [AvKARE, Inc.]

Updated Date: Jan 22, 2018 EST

US - DailyMed

16-1-2018

ACITRETIN Capsule [Impax Generics]

ACITRETIN Capsule [Impax Generics]

Updated Date: Jan 16, 2018 EST

US - DailyMed

15-1-2018

Memantine Mylan (Generics [UK] Limited)

Memantine Mylan (Generics [UK] Limited)

Memantine Mylan (Active substance: Memantine) - Centralised - Renewal - Commission Decision (2018)132 of Mon, 15 Jan 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2660/R/10

Europe -DG Health and Food Safety

10-1-2018

METHENAMINE HIPPURATE Tablet [Impax Generics]

METHENAMINE HIPPURATE Tablet [Impax Generics]

Updated Date: Jan 10, 2018 EST

US - DailyMed

10-1-2018

OXYCODONE HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

OXYCODONE HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

Updated Date: Jan 10, 2018 EST

US - DailyMed

3-1-2018

DESOWEN (Desonide) Lotion [Impax Generics]

DESOWEN (Desonide) Lotion [Impax Generics]

Updated Date: Jan 3, 2018 EST

US - DailyMed

22-12-2017

PROPRANOLOL HYDROCHLORIDE Tablet [Impax Generics]

PROPRANOLOL HYDROCHLORIDE Tablet [Impax Generics]

Updated Date: Dec 22, 2017 EST

US - DailyMed

21-12-2017

EPIRUBICIN HYDROCHLORIDE Injection [Impax Generics]

EPIRUBICIN HYDROCHLORIDE Injection [Impax Generics]

Updated Date: Dec 21, 2017 EST

US - DailyMed

11-12-2017

FAMCICLOVIR Tablet, Film Coated [Camber Pharmaceuticals, Inc.]

FAMCICLOVIR Tablet, Film Coated [Camber Pharmaceuticals, Inc.]

Updated Date: Dec 11, 2017 EST

US - DailyMed

1-12-2017

RIMANTADINE HYDROCHLORIDE Tablet, Film Coated [Impax Generics]

RIMANTADINE HYDROCHLORIDE Tablet, Film Coated [Impax Generics]

Updated Date: Dec 1, 2017 EST

US - DailyMed

1-12-2017

FLUDROCORTISONE ACETATE Tablet [Impax Generics]

FLUDROCORTISONE ACETATE Tablet [Impax Generics]

Updated Date: Dec 1, 2017 EST

US - DailyMed

29-11-2017

FAMCICLOVIR Powder [H3 Medical Inc]

FAMCICLOVIR Powder [H3 Medical Inc]

Updated Date: Nov 29, 2017 EST

US - DailyMed

21-11-2017

MIRTAZAPINE Tablet, Orally Disintegrating [Impax Generics]

MIRTAZAPINE Tablet, Orally Disintegrating [Impax Generics]

Updated Date: Nov 21, 2017 EST

US - DailyMed

13-11-2017

FAMCICLOVIR Tablet, Film Coated [Rising Pharmaceuticals, Inc.]

FAMCICLOVIR Tablet, Film Coated [Rising Pharmaceuticals, Inc.]

Updated Date: Nov 13, 2017 EST

US - DailyMed

7-11-2017

MORPHINE SULFATE Capsule, Extended Release [Impax Generics]

MORPHINE SULFATE Capsule, Extended Release [Impax Generics]

Updated Date: Nov 7, 2017 EST

US - DailyMed

6-11-2017

COLESTIPOL HYDROCHLORIDE Tablet, Film Coated [Impax Generics]

COLESTIPOL HYDROCHLORIDE Tablet, Film Coated [Impax Generics]

Updated Date: Nov 6, 2017 EST

US - DailyMed

30-10-2017

FAMCICLOVIR Tablet, Film Coated [American Health Packaging]

FAMCICLOVIR Tablet, Film Coated [American Health Packaging]

Updated Date: Oct 30, 2017 EST

US - DailyMed

24-10-2017

SEVELAMER CARBONATE Tablet, Film Coated [Impax Generics]

SEVELAMER CARBONATE Tablet, Film Coated [Impax Generics]

Updated Date: Oct 24, 2017 EST

US - DailyMed

24-10-2017

METOCLOPRAMIDE HYDROCHLORIDE Tablet [Impax Generics]

METOCLOPRAMIDE HYDROCHLORIDE Tablet [Impax Generics]

Updated Date: Oct 24, 2017 EST

US - DailyMed

19-10-2017

FAMCICLOVIR Tablet [Proficient Rx LP]

FAMCICLOVIR Tablet [Proficient Rx LP]

Updated Date: Oct 19, 2017 EST

US - DailyMed

13-10-2017

MINOCYCLINE HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

MINOCYCLINE HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

Updated Date: Oct 13, 2017 EST

US - DailyMed

10-10-2017

GLYBURIDE AND METFORMIN HYDROCHLORIDE Tablet, Film Coated [Impax Generics]

GLYBURIDE AND METFORMIN HYDROCHLORIDE Tablet, Film Coated [Impax Generics]

Updated Date: Oct 10, 2017 EST

US - DailyMed

29-9-2017

FELBAMATE Tablet [Impax Generics]

FELBAMATE Tablet [Impax Generics]

Updated Date: Sep 29, 2017 EST

US - DailyMed

27-9-2017

FENOFIBRIC ACID Capsule, Delayed Release [Impax Generics]

FENOFIBRIC ACID Capsule, Delayed Release [Impax Generics]

Updated Date: Sep 27, 2017 EST

US - DailyMed

12-9-2017

HYDROXYZINE PAMOATE Capsule [Impax Generics]

HYDROXYZINE PAMOATE Capsule [Impax Generics]

Updated Date: Sep 12, 2017 EST

US - DailyMed

8-9-2017

BUPROPION HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

BUPROPION HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

Updated Date: Sep 8, 2017 EST

US - DailyMed

7-9-2017

ORPHENADRINE CITRATE Tablet, Extended Release [Impax Generics]

ORPHENADRINE CITRATE Tablet, Extended Release [Impax Generics]

Updated Date: Sep 7, 2017 EST

US - DailyMed

7-9-2017

DANTROLENE SODIUM Capsule [Impax Generics]

DANTROLENE SODIUM Capsule [Impax Generics]

Updated Date: Sep 7, 2017 EST

US - DailyMed

22-8-2017

DEXTROAMPHETAMINE SULFATE Solution [Avadel Generics, LLC]

DEXTROAMPHETAMINE SULFATE Solution [Avadel Generics, LLC]

Updated Date: Aug 22, 2017 EST

US - DailyMed

31-7-2017

Olanzapine Mylan (Generics [UK] Limited)

Olanzapine Mylan (Generics [UK] Limited)

Olanzapine Mylan (Active substance: Olanzapine) - Centralised - Yearly update - Commission Decision (2017) 5359 of Mon, 31 Jul 2017

Europe -DG Health and Food Safety

24-7-2017

FAMCICLOVIR Tablet, Film Coated [Golden State Medical Supply, Inc.]

FAMCICLOVIR Tablet, Film Coated [Golden State Medical Supply, Inc.]

Updated Date: Jul 24, 2017 EST

US - DailyMed

10-7-2017

OXYMORPHONE HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

OXYMORPHONE HYDROCHLORIDE Tablet, Film Coated, Extended Release [Impax Generics]

Updated Date: Jul 10, 2017 EST

US - DailyMed

27-6-2017

Tadalafil Mylan (Generics [UK] Limited)

Tadalafil Mylan (Generics [UK] Limited)

Tadalafil Mylan (Active substance: tadalafil) - Referral - Commission Decision (2017)4479 of Tue, 27 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/A31/1450/C/3787/05

Europe -DG Health and Food Safety

5-6-2017

MIDODRINE HYDROCHLORIDE Tablet [Impax Generics]

MIDODRINE HYDROCHLORIDE Tablet [Impax Generics]

Updated Date: Jun 5, 2017 EST

US - DailyMed

30-5-2017

FENOFIBRATE Tablet [Impax Generics]

FENOFIBRATE Tablet [Impax Generics]

Updated Date: May 30, 2017 EST

US - DailyMed